[
Effective March 1, 2016, Independence will have new preferred
providers for both our Direct Ship Drug Program and for intravenous and
subcutaneous immunoglobulin (IVIG/SCIG) drugs provided in the home. These
changes will not affect medical necessity criteria or coverage determinations
for our members.
Direct Ship Drug Program
Walgreens and PerformRx, independent companies, have been chosen as
preferred providers for our Direct Ship Drug Program. All requests for direct
ship drugs will be fulfilled by these providers, with the exception of
Synagis®, which will continue to be fulfilled by ACRO
Pharmaceutical Services, an independent company.
Providers who currently order drugs through the Direct Ship Drug Program
will be contacted in the next few weeks to ensure there are no gaps in drug
fulfillment.
For more information on ordering drugs, go to our Direct Ship Drug
Program website.
Home infusion IVIG/SCIG
Option Care, an independent company, has been selected as the preferred
provider for IVIG/SCIG drugs given in the home. Members who receive IVIG/SCIG
from home infusion vendors that are not owned by a hospital or health system in
the Independence provider network will be transitioned to Option Care.
Independence recently sent letters to affected members notifying them of
this change and detailing the transition plan of service. Option Care will also
provide outreach to these members to answer questions and schedule appointments
with an Option Care home infusion nurse. In addition, Option Care will contact
affected providers to answer questions and obtain new prescriptions for our
members prior to the March 1, 2016, transition date.
Providers should talk to their Independence members who currently receive
IVIG/SCIG drugs to see if they have any questions or concerns.
Note: Members who currently receive IVIG/SCIG drugs through home
infusion vendors that are owned by a hospital or health system in the
Independence provider network will not be affected by this change.
]